title: Random Mutagenesis of the Aspergillus oryzae Genome Results in Fungal Antibacterial Activity.
abstract: Multidrug-resistant bacteria cause severe infections in hospitals and communities. Development of new drugs to combat resistant microorganisms is needed. Natural products of microbial origin are the source of most currently available antibiotics. We hypothesized that random mutagenesis of Aspergillus oryzae would result in secretion of antibacterial compounds. To address this hypothesis, we developed a screen to identify individual A. oryzae mutants that inhibit the growth of Methicillin-resistant Staphylococcus aureus (MRSA) in vitro. To randomly generate A. oryzae mutant strains, spores were treated with ethyl methanesulfonate (EMS). Over 3000 EMS-treated A. oryzae cultures were tested in the screen, and one isolate, CAL220, exhibited altered morphology and antibacterial activity. Culture supernatant from this isolate showed antibacterial activity against Methicillin-sensitive Staphylococcus aureus, MRSA, and Pseudomonas aeruginosa, but not Klebsiella pneumonia or Proteus vulgaris. The results of this study support our hypothesis and suggest that the screen used is sufficient and appropriate to detect secreted antibacterial fungal compounds resulting from mutagenesis of A. oryzae. Because the genome of A. oryzae has been sequenced and systems are available for genetic transformation of this organism, targeted as well as random mutations may be introduced to facilitate the discovery of novel antibacterial compounds using this system.
authors: Department of Biomedical Sciences, James H. Quillen College of Medicine, East Tennessee State University, P.O. Box 70577, Johnson City, TN 37614, USA.
authors: Cory A
authors: CA
authors: Leonard
authors: Stacy D
authors: SD
authors: Brown
authors: J Russell
authors: JR
authors: Hayman
references: Microbiology (Reading). 2010 Aug;156(Pt 8):2343-2353
references: 20447997
references: Folia Microbiol (Praha). 1970;15(1):35-9
references: 5411488
references: Int J Antimicrob Agents. 2010 Nov;36 Suppl 3:S3-7
references: 21129629
references: Nat Rev Drug Discov. 2013 May;12(5):371-87
references: 23629505
references: Metabolites. 2012 Jan 05;2(1):39-56
references: 24957367
references: J Ind Microbiol Biotechnol. 2010 Aug;37(8):805-13
references: 20440534
references: Biochem Pharmacol. 2006 Mar 30;71(7):981-90
references: 16290171
references: Nat Rev Microbiol. 2013 Jan;11(1):21-32
references: 23178386